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Microglia, the innate immune cells of the central nervous system, feature adaptive
immune memory with implications for brain homeostasis and pathologies. However,
factors involved in the emergence and regulation of these opposing responses in
microglia have not been fully addressed. Recently, we showed that microglia from the
newborn brain display features of trained immunity and immune tolerance after repeated
contact with pathogens in a dose-dependent manner. Here, we evaluate the impact of
developmental stage on adaptive immune responses of brain microglia after repeated
challenge with ultra-low (1 fg/ml) and high (100 ng/ml) doses of the endotoxin LPS
in vitro. We find that priming of naïve microglia derived from newborn but not mature and
aged murine brain with ultra-low LPS significantly increased levels of pro-inflammatory
mediators TNF-α, IL-6, IL-1β, MMP-9, and iNOS as well as neurotrophic factors
indicating induction of trained immunity (p < 0.05). In contrast, stimulation with high
doses of LPS led to a robust downregulation of pro-inflammatory cytokines and
iNOS independent of the developmental state, indicating induced immune tolerance.
Furthermore, high-dose priming with LPS upregulated anti-inflammatory mediators IL-10,
Arg-1, TGF- β, MSR1, and IL-4 in newborn microglia (p < 0.05). Our data indicate
pronounced plasticity of the immune response of neonate microglia compared with
microglia derived from mature and aged mouse brain. Induced trained immunity after
priming with ultra-low LPS doses may be responsible for enhanced neuro-inflammatory
susceptibility of immature brain. In contrast, the immunosuppressed phenotype following
high-dose LPS priming might be prone to attenuate excessive damage after recurrent
systemic inflammation.
Keywords: microglia, LPS, β-glucan, trained immunity, tolerance, maturation
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INTRODUCTION

C57BL/6J mice housed for breeding and organ harvesting were
kept at 12-h light and dark cycles with free access to food
and water.
Neonatal primary microglial cells were isolated from the
cerebral cortex of newborn mice (6–12 newborn male and female
mice brains were pooled, respectively) as described previously
(18, 19). Briefly, newborn mice were decapitated, and heads
were transferred into Petri dishes filled with ice-cold phosphatebuffered saline (PBS). Using fine scissors, the scalp was opened
carefully along the midline, and the brain was removed. Then,
meninges were removed, and cortices and hippocampi were
collected in 15-ml tubes filled with PBS. Collected brains were
processed in 2 ml dissociation media containing 200 µl 2.5%
trypsin and further supplemented with 20 µl of DNAse I in
order to digest DNA released from dead cells. After incubation
at 37◦ C and 5% CO2 for 30 min, the medium was removed, and
the brain tissues were suspended in 2 ml of Dulbecco’s modified
Eagle’s medium (DMEM, SIGMA-Aldrich #06429, endotoxin
tested) containing 10% heat-inactivated fetal bovine serum (FBS,
SIGMA-Aldrich #F7524, endotoxin-free and sterile-filtered), 1%
penicillin/streptomycin, 1% amphotericin B, supplemented with
30 µl DNAse I. Brain tissues were then homogenized and
further transferred to T75 cell culture flasks with additional 8 ml
culture medium and incubated at 37◦ C and 5% CO2 for 7
days, followed by medium change and further incubation for 7
more days.
Adult and aged male mice were sacrificed by an overdose of
isoflurane, and brains were carefully removed after transcardial
perfusion with ice-cold PBS for 5 min as described previously
(20). Briefly, whole brains from 1–2 mice were harvested,
meninges were removed, and brains were minced finely with
a scalpel in Petri dishes containing enzymatic solution as
described (21). After incubation at 37◦ C and 5% CO2
for 90 min, the enzymatic reaction was stopped by adding
Hank’s balanced salt solution (HBSS, SIGMA-Aldrich #H6648)
supplemented with 20% FBS. The tissue was centrifuged for
10 min at room temperature, and the pellet was resuspended
in HBSS containing 2 ml of 0.5 mg/mL DNAse I for 5 min.
The brain tissue was homogenized and filtered through a 70µm cell strainer. The collected cell suspension was centrifuged
for 10 min followed by a gradient density separation using
Percoll (GE Healthcare, #17-5445-02). The pellet that contained
mixed glial cells was washed with HBSS and resuspended
in culture medium supplemented with 5 ng/ml recombinant
mouse granulocyte and macrophage colony stimulating factor
(GM-CSF) (BioLegend, #576302). Suspended glial cells were
placed in T75 cell culture flasks coated with poly-L-lysine
and incubated at 37◦ C and 5% CO2 for 14 days. Medium
was changed continuously until confluence was reached on
day 14.
After 14 days, adherent microglial cells were separated from
astrocytes by adding PBS-EDTA solution and careful shaking.
After harvesting, microglial cells were seeded (75,000 cells/well)
in adherent well plates. Long-term cultures of adult microglia
were performed as previously described (20, 21). Purity of
microglia was always in the range of 95–98% as confirmed by
specific Iba1 staining (data not shown).

Microglia are the resident macrophage population that control
the patterning and wiring of the brain in early development and
contribute to homeostasis throughout life (1–4). Furthermore,
microglia implement innate immunity in the central nervous
system (CNS) as a first-line defense against invading pathogens
by continuous microenvironmental surveillance (1, 5–9).
Alterations in brain homeostasis and by most pathologic
events induce activation of microglia (10). During the activation
process, microglial cells display specific adaptive functions,
including migration toward injury, phagocytosis, antigen
presentation, and synapse remodeling (11–13). Importantly,
there is growing evidence indicating that microglial cells
may lose the ability to retransform to a completely naïve
status after activation and may remain as “postactivated” or
“primed” microglia, exhibiting potential neuropathological
relevance (2). In this connection, it has been demonstrated
that peripheral inflammatory challenges in adult mice induce
long-term alterations in microglial response, exhibiting either
enhanced or suppressed immune functions possibly exacerbating
or alleviating brain pathology in mouse models (14, 15).
These results clearly indicate microglial capacity to develop
innate immune memory (IIM), that is, long-lasting molecular
reprogramming leading to either enhanced (trained immunity)
or suppressed (immune tolerance) microglial responses to a
delayed, secondary insult (16). In agreement with previous
studies on monocytes [reviewed in (17)], we recently showed
that opposite immune responses of IIM can be induced in
microglia as a function of pathogen dose, specifically revealed for
the endotoxin LPS (14, 15, 18).
Our present report extends the investigation of dosedependent induction of IIM by evaluating the role of maturation
on microglial memory response. Primary microglial cells from
neonatal, adult, and aged mice were primed with ultra-low and
high doses of LPS, and inflammatory responses to a secondary
insult with LPS were assayed after 6 days in culture. Our data
reveal trained immunity in response to ultra-low priming doses
of LPS only in newborn microglia, whereas immune tolerance
was induced in microglia in an age-independent manner (i.e., in
naïve, mature, and aged microglia). The implications of age- and
dose-dependent priming effects for microglial functional patterns
in the CNS are discussed.

MATERIALS AND METHODS
Animals and Microglia Isolation
Procedures
Neonatal (P0–P3, n = 261), young adult (3 months old, n
= 58), and aged (24 months old, n = 36) mice from a
C57Bl/6J locally inbred mouse strain were used to isolate primary
microglial cells. All experiments were carried out according
to the guidelines from Directive 2010/63/EU of the European
Parliament on the protection of animals used for scientific
purposes and approved by the local authorities for animal
welfare (permission numbers for tissue and organ harvesting:
twz 07-2017, twz 31-2017, and twz 13-2020). Adult and aged
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Microglia Stimulation

addition of 150 µl assay reagent supplemented with IDCR. Then,
the plate was covered and shaken for 1 min in a plate shaker.
Afterwards, the plate was incubated for additional 5 min at
room temperature without shaking. Absorbance was measured
at 660 nm using a TECAN Infinite 200 Plate reader (Tecan,
Switzerland). Protein concentration was then calculated based on
the values of the standard curve (Supplementary Figure 3).
Cell viability was determined using the MTT assay. Cells were
seeded into a 96-well plate and incubated at 37◦ C (5% CO2 )
for 24 h. After attachment, primary microglial cells were treated
according to the stimulation scheme depicted in Figure 1A.
Twenty-four hours after the second LPS stimulation, MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
solution was added and incubated for 4 h at 37◦ C (5% CO2 ).
Next, the solubilization solution was added and incubated
overnight at 37◦ C (5% CO2 ) for 24 h. Absorbance was measured
at 570 nm using a TECAN Infinite 200 Plate Reader (Tecan,
Switzerland), and data were shown as relative viability (UP
assigned as 100%) (Supplementary Figure 3A).

Three different stimulation protocols were performed: (i)
Microglia were stimulated twice following a two-step (“twohit”) protocol as described elsewhere (14, 18). Microglia were
initially stimulated (“primed”) with different doses of LPS (“first
hit,” 1 fg/ml or 100 ng/ml for 24 h, respectively; E. coli serotype
055:B5 obtained from Sigma-Aldrich, St. Louis, USA) or βglucan (100 fg/ml or 1 µg/ml for 24 h). Cells were restimulated
5 days after the first challenge (day 6) by a fixed dose of LPS
(“second hit,” 100 ng/ml). Newborn, mature, and aged microglial
cells were divided into 4 groups: Microglia of the first group
were used unstimulated (US Group). The second group included
unprimed microglia (UP Group without the first hit on day 1 but
stimulated on day 6 with a fixed dose of LPS, 100 ng/ml). The
third group (ULP group) included microglia stimulated with an
ultra-low (1 fg/ml LPS or 100 fg/ml β-glucan) dose of stressors
on day 1 and restimulated at day 6 with a fixed dose of LPS
(100 ng/ml). The fourth group, labeled as the high-dose-primed
group (HP group), was stimulated with a high dose (100 ng/ml
LPS or 1 µg/ml β-glucan) of stressors and restimulated at day
6 with a fixed dose of LPS (100 ng/ml). In addition, microglia
isolated from newborn and adult mice (ii) were primed by
ultra-low (ULP, 1 fg/ml) or high (HP, 100 ng/ml) doses of LPS
repetitively once a day for 3 days (repetitive (REP) group) or one
time for 3 days (long-term [LT] group) followed by stimulation
with a fixed dose of LPS (second hit, 100 ng/ml) on day 6
after priming (Supplementary Figure 1) or (iii) stimulated by
ultra-low (ULP, 1 fg/ml) or high (HP, 100 ng/ml) doses of LPS
repetitively once a day for 3 days (repetitive (REP) group) or
one time for 3 days (LT group) without subsequent stimulation
(Supplementary Figure 2).
To evaluate the effects of repeated stimulation with LPS,
we normalized the data to the UP group (in the case
of mRNA expression). The US group served as a negative
control. Schematic overviews are shown in Figure 1A, and
Supplementary Figures 1A, 2A.

Cytokine Determination
Cytokine levels in supernatants were measured 24 h after final
stimulation (14) using enzyme-linked immunosorbent assay
(ELISA) kits for TNF-α (#430902, at a ratio of 1:40 except US
at 1:1), IL-6 (#431302, at a ratio of 1:140 except US at 1:1), and
IL-10 (#431412, at a ratio of 1:1) obtained from BioLegend (San
Diego, CA), following manufacturer’s instructions. Briefly, the
96-well plate was sealed and incubated with capture antibody
(100 µl/well) overnight at 4◦ C. The plate was washed 4 times
with washing buffer (0.05% Tween-20 in 1x PBS) and blocked
by adding 200 µl/well assay diluent (1% BSA) in order to reduce
the background and block non-specific binding. The plate was
then sealed and incubated for 1 h at room temperature in a
plate shaker (500 rpm). The plate was washed (4x) again, and
100 µl/well of prepared standards, diluted samples, and blanks
were added. The plate was sealed and incubated for 2 h at room
temperature with shaking. After 2 h, the plate was washed again
(4x) and incubated with 100 µl/well detection antibody for 1 h
at room temperature with shaking. The plate was washed again
(4x) and incubated with 100 µl/well avidin-HRP for 30 min with
shaking under dark conditions (light sensitive). Finally, after
30 min, the plate was washed (5x), and 100 µl/well of TMB
substrate solution was added. The plate was incubated in the
dark for 15–30 min, and the reaction was stopped by adding 100
µl/well of the stop solution (2N H2 SO4 ) to the wells. Absorbance
was determined with a VersaMax Microplate Reader (Molecular
Devices, USA) at 450 nm and a second reference wavelength
at 570 nm. Levels of TNF-α, IL-6, and IL-10 were normalized
against the protein concentrations of each sample and depicted
as pg/µg of total protein.

Cell Lysis and Protein Extraction
Cells were lysed using ice-cold RIPA buffer (containing 50 mM
Tris/HCl pH 8.0; 150 mM NaCl, 1% (v/v) NP-40, 0.5% (v/v)
Na-deoxycholate, 0.1% (w/v) SDS) supplemented freshly with a
protease and phosphatase inhibitor cocktail (100 mg/ml PefaBlock, 1 mg/ml Pep-statin A, 10 mM sodium vanadate, and 1
mg/ml Leupeptin). Samples were centrifuged (13,500 × g for
30 min at 4◦ C), and supernatants were mixed with 5x protein
sample buffer (5% SDS, 33% glycerol, 25% β-mercaptoethanol,
and 0.1 mg/ml bromophenol blue) and heated for 5 min at 95◦
C. Samples were used for normalization of cytokine amounts and
lactate production levels.

Measurement of the Protein Concentration
and Analysis of Cell Viability by MTT Assay

Real-Time qPCR

Total protein concentration was determined using the PierceTM
660 nm Protein Assay Kit (#22662) from Thermo Fisher Scientific
(MA, USA). Ionic detergent compatibility reagent (IDCR)
(#22663, Thermo Fischer Scientific) was used in order to reduce
interference. Briefly, 10 µl of standard, sample, and blank in
duplicates were plated in a 96-well plate, followed by immediate
Frontiers in Immunology | www.frontiersin.org

Real-time qPCR was performed 6 h after final stimulation
(14). To determine gene-expression levels, total RNA was
extracted using QIAzol Lysis Reagent (#79306) purchased from
Qiagen (Hilden, Germany). RNA concentration and quality
were checked by using a Nanodrop ND-1000 machine (Peqlab,
Erlangen, Germany). cDNA was synthesized using a RevertAid
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FIGURE 1 | Effects of maturation and priming with low and high LPS dosages on pro-inflammatory responses of murine brain microglia. Microglia isolated from
newborn (orange dots, open columns), adult (green dots, hatched columns), and aged (blue dots, gray columns) mice were primed initially by ultra-low (ULP, 1 fg/ml)
or high (HP, 100 ng/ml) doses of LPS, followed by a second stimulation (day 6) with 100 ng/ml LPS (A). The data were normalized and compared to unprimed
microglia (UP Group without any stimulation at day 1 with stimulation at day 6 with fixed dose of LPS 100 ng/ml). Unstimulated microglia served as negative control
(US Group without LPS stimulation neither at day 1 nor at day 6). RNA samples (6 h) and supernatants (24 h) were collected after the 2nd stimulation and analyzed for
gene expression of TNF-α (* indicates time point of sample collection). (B) (n = 5–6), IL-6 (D) (n = 4–5), IL-1β (F) (n = 5), and iNOS (G) (n = 4–5) (unprimed cells
assigned as 1.0) and cytokine production of TNF-α (C) (n = 7–8) and IL-6 (E) (n = 6–8) by ELISA (normalized to total protein concentration). Data shown in scatter dot
plots represent means + SEM, # p < 0.05 vs. unprimed conditions within each age group (naïve or mature), § p < 0.05 vs. adult microglia within each stimulation
condition (US, UP, ULP, HP).
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(H2 DCFDA; #D399, Thermo Fisher Scientific, Waltham, MA,
USA), a membrane-permeable reduced form of fluorescein,
which reacts with reactive oxygen species, thereby emitting
fluorescence light. For this, microglial cells were seeded
into white clear-bottom 96-well plates (30,000 cells/well).
After becoming adherent, cells were stimulated as described
above. For measurement, the medium was aspirated, and 200
µl/well of H2 DCFDA-solution (stock 50 mM 1:1000 in 10 mM
HEPES/CaCl2 ) was added, and cells were incubated for 20 min
at 37◦ C. Thereafter, cells were carefully washed twice with an
HEPES/CaCl2 solution. Measurement of intracellular ROS levels
was performed at 485 nm excitation and 535 nm emission using
a TECAN Infinite 200 Plate reader (Tecan, Switzerland).

TABLE 1 | Primers used in the study.
Gene name

Primer Sequences (5′ - 3′ )

Tnf-a

Fw CTGTAGCCCACGTCGTAGC

Tumor necrosis factor-a

Rev TTGAGATCCATGCCGTTG

Il-6

Fw CCTCTCTGCAAGAGACTTCCATCCA

Interleukin-6

Rev GGCCGTGGTTGTCACCAGCA

iNOS

Fw AAGGCCACATCGGATTTCAC

Inducible nitric oxide synthase

Rev GATGGACCCCAAGCAATACTT

Il-1β

Fw GGCAGGCAGTATCACTCATT

Interleukin 1 β

Rev AAGGTGCTCATGTCCTCAT

MMP-9

Fw ACCACTAAAGGTCGCTCGGATGG

Matrix metallopeptidase 9

Rev AGTACTGCTTGCCCAGGAAGACG

Il-10

Fw ACCAGCTGGACAACATACTGC

Interleukin 10

Rev TCACTCTTCACCTGCTCCACT

Il-4

Fw TGGGTCTCAACCCCCAGCTAGT

Interleukin 4

Rev TGCATGGCGTCCCTTCTCCTGT

Arg-1

Fw TCACCTGAGCTTTGATGTCG

Arginase-1

Rev CTGAAAGGAGCCCTGTCTTG

TGF- β

Fw TGCTTCAGCTCCACAGAGAA

Transforming growth factor β

Rev TACTGTGTGTCCAGGCTCCA

Msr1

Fw TGGAGGAGAGAATCGAAAGCA

Macrophage scavenger receptor 1

Rev CTGGACTGACGAAATCAAGGAA

Bdnf

Fw GACAGTATTAGCGAGTGGGTCA

Brain derived neurotrophic factor

Rev CCTTTGGATACCGGGACTTT

Pfkfb3

Fw GGAGAGGTCAGAGGATGCAAA

6-phosphofructo-2-kinase/fructose2,6-biphosphatase 3

Rev GCTGTTGATGCGAGGCTTTT

Tlr4

Fw ACCTGGCTGGTTTACACGTC

Toll-like receptor 4

Rev CAGGCTGTTTGTTCCCAAAT

MyD88

Fw TCCGGCAACTAGAACAGACAGACT

Myeloid differentiation primary
response 88

Rev GCGGCGACACCTTTTCTCAAT

Irak4

Fw GTCATGACCAGCCGAATCGTG

Interleukin−1 receptor-associated
kinase 4

Rev CAGACACTGGTCAGCAGCAGA

p65

Fw CTTCCTCAGCCATGGTACCTCT

Transcription factor p65

Rev CAAGTCTTCATCAGCATCAAACTG

Gapdh

Fw CATGGCCTTCCGTGTTTCCTA

Glyceraldehyde 3-phosphate
dehydrogenase

Rev CCTGCTTCACCACCTTCTTGAT

Hmbs

Fw GTTGGAATCACTGCCCGTAA

Hydroxymethylbilane synthase

Rev GGATGTTCTTGGCTCCTTTG

Lactate Production Measurement
Supernatants from microglial cultures were used to measure
lactate production by sequential enzymatic reactions [according
to Lin et al. (23)]. Briefly, lactate is converted by lactate oxidase
(LO; #L0638, Sigma-Aldrich) to pyruvate and H2 O2 . In a second
reaction, the chromogenic substrate ABTS (#A1888, SigmaAldrich) is converted to a colored dye, catalyzed by horseradish
peroxidase (HRP; #77332, Sigma-Aldrich) in the presence of
H2 O2 and measured at 405 nm. Lactate levels were normalized
to the total protein concentration of each sample.

Statistical Analysis
Statistical analysis was carried out using SigmaPlot Software
Version 13.0 Build 13.0.0.83 (Systat Software GmbH, Erkrath,
Germany). Data are presented as scatter dot plots showing
means ± SEM. Comparison between experimental groups and
conditions were analyzed with two-way analysis of variance
in all cases for the factors “Group” (three different age
groups) and “State,” which consists of US (unstimulated), UP
(unprimed), ULP (ultra-low primed), and HP (high primed). In
all cases, interaction between both factors were analyzed. Post-hoc
comparisons were made with the Holm–Sidak test. Differences
were considered significant when p < 0.05.

RESULTS
Effect of Priming With Low and High LPS
Doses on Cytokine and iNOS Levels in
Newborn, Adult, and Aged Microglia
Gene expression and protein levels of pro-inflammatory
cytokines TNF-α, IL-6, and IL-1β were evaluated after repeated
LPS stimulation in newborn, mature, and aged microglia and
compared with related unstimulated (US) and unprimed (UP)
microglial cells. As expected, US microglia expressed low
cytokine levels (Figures 1B–E, p < 0.05). A single challenge
with 100 ng/ml LPS (UP) led to a marked increase in levels
of TNF- α, IL-6, and IL-1β in microglia in all groups (p <
0.05). Microglial priming with the ultra-low LPS dose (ULP)
followed by a standard fixed LPS dose 5 days later further
increased levels of TNF-α (Figures 1B,C), IL-6 (Figures 1D,E),
and IL-1β (Figure 1F) in newborn microglia, indicating trained
immunity (p < 0.05). No such effect was observed in mature
and aged microglia for TNF-α and IL-6 after stimulation,

First Strand cDNA Synthesis kit (#K1612) from Thermo Fisher
Scientific (Waltham, MA, USA). qPCR reaction was performed
by using a LightCycler 480 SYBR Green (Roche, Switzerland) and
Rotor gene Q machine (Qiagen, Germany). Primers used in the
study are listed in Table 1. Housekeeping genes, GAPDH and
HMBS, were used for normalization. Relative gene expression
was calculated by the comparative CT (2T−11C ) method (22).

Measurement of Reactive Oxygen Species
(ROS)
ROS were measured using the H2 DCFDA assay. The assay
is based on the use of 2′ ,7′ -dichlordihydrofluorescein-diacetat
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Effect of Priming With Low and High LPS
Dosages on ROS, BDNF, and Metabolic
Indicators in Newborn, Adult, and Aged
Microglia

whereas IL-1β was increased in microglia obtained from
adult mice (Figure 1F, p < 0.05). In addition, expression
of MMP-9, an important activation marker for microglia,
was upregulated after low-dose LPS priming in newborn
but not in mature microglia (Supplementary Figure 4E, p <
0.05). These results may suggest that induction of trained
immunity leads to a pro-inflammatory phenotype mainly in
newborn microglia.
In contrast, microglial priming with LPS at high doses
(HP) led to a robust downregulation of pro-inflammatory
cytokines in all groups 5 days after renewed challenge with
LPS 100 ng/ml, indicating induced immune tolerance (p <
0.05). A similar effect was observed for mRNA expression of
iNOS with newborn microglia displaying both trained immunity
after priming with ultra-low LPS doses and tolerance after
priming with high LPS concentrations (Figure 1G, p < 0.05).
Mature and aged microglia did not show a significant response
at either ultra-low or high LPS doses as compared with the
unprimed group.
In order to determine whether induction of trained immunity
or tolerance shifts the microglial phenotype to an antiinflammatory state, we assessed microglial gene expression
and protein level of anti-inflammatory IL-10 as well as
of the immunosuppressive mediators Arg-1, TGF-β, and
IL-4. Strikingly, IL-10 release was manyfold enhanced in
supernatants of adult microglia under unstimulated conditions
and after stimulation, irrespective of the stimulation procedure
(Figure 2B, p < 0.05). Furthermore, increased gene expression
and production of IL-10 after high-dose LPS priming appeared
in newborn microglia (Figures 2A,B, p < 0.05). In addition
priming with ultra-low LPS doses had no effect on levels of IL-10
and Arg-1 in microglia of all age groups under consideration
(Figure 2). Priming with a high LPS dose increased gene
expression of Arg-1, TGF-β, and IL-4 in newborn microglia as
well as in aged microglia for Arg-1, but not in adult microglia
(Figures 2C–E, p < 0.05). Furthermore, MSR1 was upregulated
in newborn and adult microglia (Supplementary Figure 4F,
p < 0.05). This indicates that induction of tolerance
in naïve and mature microglia is associated with an
anti-inflammatory phenotype.
Repetitive stimulation with low and high LPS dosages for
a period of 3 days induced similar dose- and maturationdependent microglial responses for TNF-α and IL-6
(Supplementary Figure 1, p < 0.05) as shown in response
to one-time priming. In contrast, a single stimulation with
an ultra-low LPS dose did not induce any response, whereas
stimulation with high-dose LPS induced the anticipated marked
pro-inflammatory response (Supplementary Figure 2, p <
0.05). These response patterns appeared irrespective of the
mode of stimulation (e.g., one-time or repetitive stimulation),
and cell viability of naïve and mature microglia appeared to be
similar (Supplementary Figure 3). Furthermore, exploration of
molecular mechanisms underlying the demonstrated microglial
training effects revealed that priming with low LPS doses is
induced by increased TLR4/MyD88/IRAK-4 activation only
in naïve microglia (p < 0.05), whereas immune tolerance is
mediated by reduced TLR4/MyD88/IRAK-4 activation in both
naïve and mature microglia (Supplementary Figure 4, p < 0.05).
Frontiers in Immunology | www.frontiersin.org

Considering that reactive oxygen species (ROS) represent
important executing molecules of innate immunity, we evaluated
the impact of maturation and LPS dose on ROS production in
microglia derived from newborn, adult, and aged mice brains.
As shown in Figure 3A, unstimulated newborn naïve microglia
showed distinctly lower ROS levels as compared with adult
and aged microglia. Single stimulation with LPS significantly
increased ROS levels in all microglia populations (Figure 3A, p
< 0.05). ROS levels remained reduced in newborn microglia,
whereas aged microglia exhibited increased ROS levels compared
with adult microglia. Priming with ultra-low LPS doses followed
by a second challenge 5 days later (day 6) further increased
ROS levels in newborn (p < 0.05) but not in mature microglial
cells. This response further supports induction of trained innate
immunity as an exclusive feature of newborn microglia. In
contrast, priming with high-dose LPS reduced ROS levels only
in newborn and adult cell populations (p < 0.05), supporting
induction of a tolerance state.
Given the widespread functional role of brain-derived
neurotrophic factor (BNDF) released by microglia in
physiological processes involved in learning and memory (24)
and also in pathological events such as neuronal disinhibition of
the intrinsic inhibitory system, causing neuropathic pain after
peripheral nerve injury (25, 26), we evaluated the impact of the
developmental state on gene regulation of microglial BNDF after
repeated challenge with LPS. Priming with an ultra-low LPS dose
increased BNDF expression in newborn microglia but reduced it
strongly in adult microglia (Figure 3B, p < 0.05). Furthermore,
priming of newborn microglia with high-dose LPS led to a
diminished response after the second LPS stimulus compared
with the unprimed state (p < 0.05). In mature microglial cells,
high-dose priming with LPS further decreased BDNF expression
(p < 0.05). Interestingly, after both ultra-low and high priming
doses of LPS, BDNF expression levels appeared significantly
higher in newborn and aged microglia when compared with
adult microglia (p < 0.05).
Considering that metabolic reprogramming has been
identified to be a crucial step for the induction of trained
immunity in peripheral innate immune cells (27), we assessed
the expression of 6-phosphofructo-2-kinase/fructose-2,6biphosphatase (PFKFB)3, a rate-limiting enzyme of glycolysis
and lactate production, in newborn, adult, and aged microglia.
As shown in Figure 3C, gene expression of the glycolytic enzyme
PFKFB3 was slightly increased in unstimulated microglia
obtained from aged mice (p < 0.05), but baseline lactate
concentration was enhanced in the supernatant of newborn
naïve microglia (Figure 3D, p < 0.05). Priming with the ultralow LPS dose induced a significant increase in PFKFB3 gene
expression in newborn microglia as well as enhanced lactate
concentration (Figures 3C,D, p < 0.05). In contrast, priming
with high-dose LPS significantly reduced lactate concentration
in the supernatants of newborn naïve microglia cultures
(Figure 3D, p < 0.05).
6
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FIGURE 2 | Effect of maturation and priming with low and high LPS dosages on anti-inflammatory responses of murine brain microglia. Microglia isolated from
newborn (orange dots, open columns), adult (green dots, hatched columns), and aged (blue dots, gray columns) mice were primed initially by ultra-low (ULP, 1 fg/ml)
or high (HP, 100 ng/ml) doses of LPS, followed by a second stimulation (day 6) with 100 ng/ml LPS. The data were normalized and compared to unprimed microglia
(UP Group without any stimulation at day 1 with stimulation at day 6 with a fixed dose of LPS 100 ng/ml). Unstimulated microglia served as negative control (US Group
without LPS stimulation neither at day 1 nor at day 6). RNA samples (6 h) and supernatants (24 h) were collected after the 2nd stimulation and analyzed for gene
expression of IL-10 (A, n = 4–5), Arg-1 (C, n = 3–5), TGF-β (D, n = 3–5), and IL-4 (E, n = 3–5) (unprimed cells assigned as 1.0) and cytokine production of IL-10 (B, n
= 5–6) by ELISA (normalized to total protein concentration). Data shown in scatter dot plots represent means + SEM, # p < 0.05 vs. unprimed conditions within each
age group (naïve or mature), § p < 0.05 vs. adult microglia within each stimulation condition (US, UP, ULP, HP).

Effect of Priming With Low and High
β-glucan Dosages on Cytokine Levels in
Newborn, Adult, and Aged Microglia

with LPS (100 ng/ml) at day 6. Priming with ultra-low β-glucan
doses further increased levels of TNF-α and IL-6, and high
concentrations reduced release of both cytokines in newborn
microglia (Figure 4, p < 0.05). In contrast, adult and aged
microglia did not show a relevant response to β-glucan. These
findings suggest a β-glucan-mediated dose-dependent induction
of trained immunity and tolerance only in newborn microglia as
previously shown for LPS (14, 15, 18).

In order to further characterize the impact of maturation on
microglial response after repeated challenge with PAMPs, cells
were primed with different doses of β-glucan, a fungal cell wall
component from Candida albicans, followed by a stimulation
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FIGURE 3 | Effect of maturation and priming with low and high LPS dosages on ROS production, BDNF, and metabolic rewiring of murine brain microglia. Microglia
isolated from newborn (orange dots, open columns), adult (green dots, hatched columns), and aged (blue dots, gray columns) mice were primed initially by ultra-low
(ULP, 1 fg/ml) or high (HP, 100 ng/ml) doses of LPS, followed by a second stimulation (day 6) with 100 ng/ml LPS. The data were normalized and compared to
unprimed microglia (UP Group without any stimulation at day 1 with stimulation at day 6 with fixed dose of LPS 100 ng/ml). Unstimulated microglia served as negative
control (US Group without LPS stimulation neither at day 1 nor at day 6). RNA samples (6 h) and supernatant (24 h) were collected after the 2nd stimulation and
analyzed for ROS production (A, n = 3–8, repeated measurements) and gene expression of BDNF (B, n = 4–5), and PFKFB3 (C, n = 4–5) (unprimed cells assigned as
1.0) as well as lactate concentration in supernatant (D, n = 5–6). Data shown in scatter dot plots represent means + SEM, # p < 0.05 vs. unprimed conditions within
each age group (naïve or mature), § p < 0.05 vs. adult microglia within each stimulation condition (US, UP, ULP, HP).

DISCUSSION

conditions of PAMP confrontation. Furthermore, our data reveal
that the fungal cell wall constituent β-glucan also provokes
development- and dose-dependent training and tolerance
responses. Considering that β-glucan is recognized by a different
receptor as LPS (Dectin-1 vs. TLR-4), these data provide evidence
that similar microglial responses (increased levels of TNF and
IL-6 after ULP) might arise after stimulation with compounds
that mimic different types of infections and develop into trained
immunity. Notably, a remarkable shift of the sensitivity of
the affected microglial cells can be relevant. Whereas, LPSinduced training was observed at 1 fg/ml LPS, β-glucan provokes
training at 100 fg/ml. Different effective concentrations of LPS
and β-glucan might result from varying affinities of the TLR4 and Dectin-1 receptors binding these two PAMPs. The high
sensitivity of microglia to LPS might be a special characteristic
of neonatal cells (30).
The observed training responses of microglia derived from
neonatal mouse brains after priming with an ultra-low LPS dose

Our study supports recent evidence indicating memory-like
responses of brain microglia after repeated immune challenge
(14, 15, 18). Corroborating our previous report (14, 15, 18),
priming of neonatal microglia with low doses of LPS was
found to increase release of pro-inflammatory cytokines after
the second challenge, whereas priming the cells with high
doses of LPS induces tolerance (i.e., decreased release of these
cytokines). Collectively, these findings fit into the paradigm
of pathogen dose-dependent training and tolerance responses
recently developed for peripheral innate immune cells (28, 29).
In our present study, we show for the first time, that the
patterns of adaptive responses in microglia are regulated by
the developmental state of these cells. Moreover, independently
of the mode of priming (one-time vs. repetitively) microglia
consistently developed an immune response suggesting that
microglial immune memory can play a role under widespread
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FIGURE 4 | Effect of maturation and priming with low and high β-glucan dosages on proinflammatory responses of murine brain microglia. Microglia isolated from
newborn (orange dots, open columns), adult (green dots, hatched columns), and aged (blue dots, gray columns) mice were primed initially by ultra-low (ULP, 100
fg/ml) or high (HP, 1 µg/ml) doses of β-glucan, followed by a second stimulation (day 6) with 100 ng/ml LPS. The data were normalized and compared to unprimed
microglia (UP Group without any stimulation at day 1 with stimulation at day 6 with fixed dose of LPS 100 ng/ml). Unstimulated microglia served as negative control
(US Group without β-glucan stimulation neither at day 1 nor at day 6). Supernatants were collected 24 h after the 2nd stimulation and analyzed for TNFα (A) (n = 4–8)
and IL-6 (B) (n = 5–8) levels by ELISA (normalized to total protein concentration). Data shown in scatter dot plots represent means + SEM, # p < 0.05 vs. unprimed
conditions within each age group (naïve or mature), § p < 0.05 vs. adult microglia within each stimulation condition (US, UP, ULP, HP).

raises the question of whether this challenge is of physiological
relevance or may result from particular experimental conditions.
Previous studies revealed that LPS is extraordinarily potent
and able to stimulate host responses even in the femtomolar
range corresponding to about 100 invading Gram-negative
bacteria (31–33). Mechanistically, the LPS-induced immune cell
activation is mediated by TLR4 (34, 35). Receptor activation
requires binding of an individual LPS molecule (LPS monomer)
to the MD-2/TLR4 dimeric receptor (36) and dimerization of
the LPS.MD-2.TLR4 ternary complex (37). In turn, as few as 25
LPS MD-2.TLR4 complexes per cell can trigger measurable proinflammatory responses, implying very efficient oligomerization
of these ternary complexes (38). Therefore, priming effects with
ultra-low LPS doses are apparently potent enough to control
intracellular training effects important for innate immune
memory in neonatal microglia as we have shown previously (18).
Mature microglia also responded to ultra-low LPS priming with
increased expression of TLR4, MyD88, and IRAK-4 but exhibited
no upregulation of the key transcription factor p65, suggesting a
loss of pro-inflammatory-mediated activation via the canonical
NF-κB pathway (Supplementary Figure 4) (39, 40). In contrast,
priming with a high LPS dosage was accompanied by a
suppression of the pro-inflammatory TLR4-IRAK-4-p65 axis,
indicating induced immune tolerance (41, 42).
In contrast to the trained response pattern of neonatal
microglia, microglia derived from mature mice brains did
not exhibit a similar reinforced response after priming with
ultra-low doses of LPS. These findings are in line with a
previous study on primary microglia isolated from adult mice,
indicating development of immune tolerance but not training,
after stimulation with high doses of LPS (14). In our hands,
microglia derived from aged mice showed a shift toward
downregulation of pro-inflammatory cytokines and upregulation
of anti-inflammatory mediators after priming with an ultra-low
LPS dose. These findings are also in line with previous evidence
showing that, with aging, sensome transcripts for endogenous
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ligand recognition are downregulated, whereas those involved in
host defense are upregulated. Furthermore, aging was associated
with an overall increase in the expression of microglial genes
involved in neuroprotection (43).
Therefore, increased sensitivity of immature microglia toward
low doses of microbial PAMPs and their downward turn
during the maturation process appear to be a tightly regulated
adaptive response of the innate immune cells in the brain to
the microbial gut population, possibly associated with intense
brain–gut interactions (44, 45). Specifically, recent studies have
shown that microglial development proceeds in a stepwise
manner with strong variations between different regions of
the CNS, driven by transcriptional and epigenomic regulation
and mediated by distinct pathways responsible for processing
the relevant signals from the environment to balance their
time-dependent role in neurogenesis with the regulation of
immune responses (46, 47). Clearly, host microbiota represent
a major environmental factor for microglial maturation and
markedly modulates microglia properties. Therefore, microglial
homeostasis after maturation is mainly regulated by microbiotaderived bacterial fermentation products and mediated by histone
modifications (48). However, due to proper microbial gut
colonization during the neonatal period, a microglial maturation
spurt occurs, which is characterized by increased proliferation
and enhanced expression of genes associated with inflammation
and defense response (46, 49). Furthermore, several processes,
including synaptogenesis, regulation of neurotransmitters and
neurotrophic factors (50), blood–brain barrier tightness, and
upregulated expression of tight junction proteins, among others,
are mediated by microbiota–brain communication (51). In
addition, it appears that early microglial confrontation with
microbiota-derived TLR4 ligands is essential to prime brain
immune competence not only for microbial challenges, but also
for viral infections (52, 53).
Interestingly, priming with an ultra-low LPS dose did not
induce an accompanying anti-inflammatory cytokine response as
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from newborn pups exhibiting a dose-dependent response after
priming (e.g., trained immunity and immune tolerance). These
data suggest that the immature brain appears to be especially
vulnerable against oxidative stress. There is compelling evidence
that high concentrations of unsaturated fatty acids, a high rate
of oxygen consumption, low concentrations of antioxidants,
and increased availability of “free” redox-active iron might be
responsible for this effect (62–64).
The in vitro approach used in our study has several
advantages compared to in vivo approaches and permits
the identification of basic molecular mechanisms involved
in microglial priming under specific experimental conditions,
avoiding the effect of paracrine factors or complex environmental
effects. We used primary cells instead of immortalized cell
lines, which more closely resemble cellular entities in the
naïve tissue (21, 65). The presented data reveal no relevant
difference in cell viability and protein concentration between
age groups and experimental procedures, suggesting comparable
cellular responses between naïve and mature microglial cells
(Supplementary Figure 3).
On the other hand, we have to consider several limitations
inherent to the microglial cell culture approach used. First
of all, it is well-known that microglial cells react to the
cell culture environment with the consequence that in vitro
studies may not faithfully reflect properties of microglia under
physiological conditions (8). Furthermore, the translational value
of data obtained from microglial cell culture studies is somehow
limited due to the complex function of microglial cells in
brain tissues. In particular, microglia, considered to be the
prototypic tissue-resident macrophage-like innate immune cells
of the CNS, are multifunctional cells that interact with numerous
other cells in the CNS, including neurons, astrocytes, and
oligodendrocytes (66). In vitro studies using cell cultures with
isolated microglia preclude per se these essential interactions
given in brain tissue. Therefore, response patterns of microglia
are curtailed inevitably but deliver important reference points
for subsequent and productive translational research. Recently,
seminal contributions to preclinical neurological research have
been published that identify immune memory in the brain
as an important modifier of neuropathology under in vivo
conditions (15). Specifically, peripherally applied inflammatory
stimuli induce acute immune training and tolerance in the
brain and lead to differential epigenetic reprogramming in
microglia that persists for several months. Strikingly, in a mouse
model of Alzheimer’s pathology, immune training exacerbated
cerebral β-amyloidosis, and immune tolerance alleviated it (16).
Similarly, peripheral immune stimulation modified pathological
features after stroke. This evidence impressively demonstrates
the role of microglial immune memory in pathological
hallmarks of neurological disease in mouse models, which
is obviously consistent with certain clinical observations in
patients (16).
Another source of limitations may result from methodical
reasons. For example, in this study, we used exclusively male
adult and aged mice for microglial cell isolation in order to
compare it with previous studies in male mice in our lab,
involving aging and senescence of microglia (20).

indicated by a missing IL-10 elevation in the three age groups
studied (Figure 2). The rationale for these findings cannot be
drawn from our results. Nevertheless, it can be speculated that
microglia respond to priming with ultra-low LPS doses, such
as leukocytes with non-resolving inflammatory adaptation, by
removal of negative modulators, disallowing the development
of anti-inflammatory tolerance and favoring the inflammatory
monocyte adaptation (54).
Intriguingly, microglial immune tolerance resulting in a
dampened pro-inflammatory response after repeated highdose LPS challenge was similar in the different age states
under consideration. Obviously, tight control of the neuroinflammatory response over time appears to be an imperative
prerequisite to preserve brain tissue from harm due to
overwhelming inflammation. Therefore, the high dose-tolerance
effects might mainly reflect a regulatory response resulting
from IL-10 upregulation in immature microglia (18). This
consideration derived from our data is in line with previous
reports and may preclude an exhaustion of the machinery to
produce pro-inflammatory cytokines [for review, see Lobo-Silva
et al. (55)]. In contrast, microglial restorative activity at high-dose
LPS was more pronounced in microglia derived from newborn
mice, underscoring the inherent neuroprotective capacity of
immature microglia. This specific response pattern of neonatal
microglia might be relevant for the compensation of vulnerable
effects of inflammation in the immature brain (56).
Importantly, expression of the PAMP receptor TLR-4, its
associated protein MyD88, and the key downstream kinase
IRAK-4 (which promotes phosphorylation of IRAK-1), which
is essential for TLR-mediated NF-κB activation, were increased
after priming with ultra-low LPS dose in naïve and mature
microglia (Supplementary Figure 4). However, upregulation of
p65, a key element for NF-kB activation, exhibited a pronounced
training response only in primed newborn microglia. In contrast,
priming with a high dose was accompanied by downregulation of
the NF-kB in both age groups, indicating the molecular basis of
induced immune tolerance in microglia. Strikingly, sensitization
of NF-kB by priming with a lower LPS dosage (herein seen in
naïve microglia) and tolerance development by a higher LPS
dose (observed in naïve and mature microglia) has been recently
observed by single-cell analysis and assigned to a dose-sensing
autoregulatory loop via IL-1R-associated kinase 1 (IRAK1) (57).
Current research identifies metabolic reprogramming as a key
hallmark of innate immunity along with immune cell activation.
It is characterized by a fine-tuned pattern of metabolic conditions
that become rewired after repeated immunological challenges,
probably via epigenetic modifications (58, 59). We find here that
trained immunity driven by repeated LPS challenges in newborn
microglia is associated with a shift toward aerobic glycolysis
as the dominating immunometabolic process herein. PFKFB3driven macrophage glycolytic metabolism is found to be a crucial
component of the innate immune response (60). Induction of
the glycolytic activator PFKFB3 and increased lactate production
suggest a possible TCA-cycle remodeling, probably by itaconate,
as previously described elsewhere (61).
Release of reactive oxygen species was several times higher
by mature and aged microglia compared to microglia derived
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Consequently, we have to consider that this approach
may restrict the spectrum of response patterns given under
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